Immunovant, Inc. Annual Earnings Per Share, Basic in USD/shares from 2020 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Immunovant, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2023.
  • Immunovant, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.74 USD/shares, a 64.4% decline year-over-year.
  • Immunovant, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -2.2 USD/shares, a 11.7% decline year-over-year.
  • Immunovant, Inc. annual Earnings Per Share, Basic for 2023 was -1.88 USD/shares, a 9.94% decline from 2022.
  • Immunovant, Inc. annual Earnings Per Share, Basic for 2022 was -1.71 USD/shares, a 19.6% decline from 2021.
  • Immunovant, Inc. annual Earnings Per Share, Basic for 2021 was -1.43 USD/shares, a 17.2% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2 $0 -9.94% Apr 1, 2023 Mar 31, 2024 10-K 2024-05-29
2022 -$2 $0 -19.6% Apr 1, 2022 Mar 31, 2023 10-K 2024-05-29
2021 -$1 $0 -17.2% Apr 1, 2021 Mar 31, 2022 10-K 2023-05-22
2020 -$1 Apr 1, 2020 Mar 31, 2021 10-K 2022-06-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.